Advances in cancer chemotherapy.
D001761:Bleomycin / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000188:drug therapy; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D002822:Choriocarcinoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D008938:Mitosis / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D011247:Pregnancy; D012878:Skin Neoplasms / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D001761:Bleomycin; D014750:Vincristine; D008130:Lomustine; D003606:Dacarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate